This is a preview of subscription content, log in via an institution to check access.
References
Falk RH, Alexander KM, Liao R, Dorbala S. AL (light-chain) cardiac amyloidosis: A review of diagnosis and therapy. J Am Coll Cardiol 2016;68:1323‐41.
Kessler L, Kupusovic J, Ferdinandus J, Hirmas N, Umutlu L, Zarrad F. Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI PET. Clin Nucl Med 2021;46:807‐13.
**ng HQ, Gong JN, Chen BX, Guo XJ, Yang YH, Huo L, et al. Comparison of 68Ga-FAPI imaging and cardiac magnetic resonance in detection of myocardial fibrosis in a patient with chronic thromboembolic pulmonary hypertension. J Nucl Cardiol 2021. https://doi.org/10.1007/s12350-020-02517-2.
Siebermair J, Köhler MI, Kupusovic J, Nekolla SG, Kessler L, Ferdinandus J, et al. Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling. J Nucl Cardiol 2021;28:812‐21.
Cook J, Muchtar E, Warsame R. Updates in the diagnosis and management of AL amyloidosis. Curr Hematol Malig Rep 2020;15:155‐67.
Guo W, Chen H. 68Ga FAPI PET/MRI in cardiac amyloidosis. Radiology 2021. https://doi.org/10.1148/radiol.211951.
Funding
This work was supported by Bei**g Hospitals Authority Clinical Medicine Development of Special Funding Support (ZYLX202105).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Min-Fu Yang is the recipient of the grant from Bei**g Hospitals Authority Clinical Medicine Development of Special Funding Support (ZYLX202105). The rest of the authors declared no conflict of interest.
Ethical approval
This study was approved by the Institutional Ethics Committee of Bei**g Chaoyang Hospital (2021-ke-596). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or National Research Committee and in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Written informed consent was obtained from the patient for the anonymous use of patient clinical and imaging data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
**, XY., Wang, L., Liu, A. et al. Myocardial fibroblast activation imaging in light chain cardiac amyloidosis. J. Nucl. Cardiol. 30, 1690–1692 (2023). https://doi.org/10.1007/s12350-022-02963-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-022-02963-0